Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detecting Liver Metastatic Lesions in Patients of Colorectal Cancer With Novel Precise Imaging Tools

NCT06935149 is registered in ClinicalTrials.gov with Primo Biotechnology Co., Ltd as lead sponsor.

NCT NCT06935149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06935149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detecting Liver Metastatic Lesions in Patients of Colorectal Cancer With Novel Precise Imaging Tools
Lead sponsor
Primo Biotechnology Co., Ltd
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2025
Completion date
June 30, 2026
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver metastasis colon cancer